Gene Therapy Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Lung Cancer
Data on lung cancer detailed by W.S. Chen and co-authors
December 18th, 2008
According to recent research from the United States, "Ambiguous roles of genotoxic anticancer therapeutic-induced NF-kappa B activation in regulating gene expression (activation or suppression) and apoptosis (anti- or pro-apoptosis) have recently been suggested. In order to clarify this controversy and determine the usefulness of NF-kappa B blockage for sensitizing anticancer therapy, we have systematically investigated the effect of distinct NF-kappa B-blocking approaches on lung cancer cells' responses to Adriamycin-induced cytotoxicity." "The results show that Adriamycin-induced NF-kappa B activation functions as a transcriptional activator triggering the expression...
Source: Gene Therapy Weekly (2008-12-18)
|
